Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 317

Review creates challenges for super outcomes

The recently released Capability Review of the Australian Prudential Regulation Authority (APRA) made three recommendations that are specifically aimed at superannuation. These recommendations hold significant implications for how the industry might be regulated in future.

Recommendation 5.1 calls for the establishment of a dedicated Superannuation Division within APRA. This sensible proposal recognises that superannuation differs in fundamental ways from banking and insurance. Superannuation funds invest on behalf of members for uncertain outcomes, and fund trustees have a fiduciary duty to members. Banks and insurance companies make promises related to fixed amounts, and the duty of directors has (traditionally) been to the shareholders that provide the capital. Superannuation should be viewed through a dedicated lens.

Recommendations 5.2 and 5.3 are aimed at cementing member outcomes as a central focus for APRA. This will inevitably change the aspects that it pays attention to when regulating the industry.

The remainder of this article discusses some issues that arise from this shift in focus.

A move from financial stability to member outcomes

As a prudential regulator, APRA’s role is forward-looking and relates to how the financial industry operates and the potential implications. Its mandate spans a broad range of elements, with Section 8(2) of its governing act stating:

“APRA is to balance the objectives of financial safety and efficiency, competition, contestability and competitive neutrality and, in balancing these objectives, is to promote financial system stability in Australia.”

Until recently, APRA pursued its mandate within superannuation by primarily addressing the financial stability of the funds themselves. The Review issues a loud shout for APRA to focus on member outcomes. This gives impetus to a shift that was already underway following the Hayne Royal Commission, both within APRA itself, and through the recent ‘member outcomes’ bill giving it power to take corrective action against funds that are not acting in members’ best interests.

The Review envisages APRA becoming a champion for members, backed up by the structure, resourcing and ethos to do so.

Previous mechanisms have been weak

The broad thrust of focusing on member outcomes is welcome. Although fund trustees have a fiduciary duty to act in the interests of members, the problem is that the mechanisms for ensuring that trustees are doing their jobs properly have been weak. The members themselves do not apply much pressure. Their main disciplining mechanism is through exercising fund choice, but most members lack the interest, knowledge or confidence to do so. Many just accept the default, often on trust.

Gatekeepers like corporate sponsors and financial advisers can exert some influence, but operate only in certain parts of the market. Research and consulting houses offer fund comparisons. However, none of these groups can be relied on to champion member interests in a comprehensive manner.

Having APRA on the look-out for member interests will provide both a valuable check on whether funds are doing what is best for their members, and a source of stimulus for change when required. The fact that funds know that APRA is watching will help ensure they stay in line.

Nevertheless, there are issues around implementation. Member outcomes are delivered at the product and service level. How deep does APRA go? At the top end, APRA could aim to satisfy itself that funds are giving deep consideration to member interests in designing their product offerings and ancillary services such as advice. At the bottom end, APRA might drill down to examine the products or services in some depth. It currently does this with MySuper authorisation.

Will APRA push at a product level?

The Review seems to be implying a deeper product-level focus. Recommendation 5.2 suggests that APRA: “publish objective benchmarks on product performance” and “collect product level data that facilitates accurate assessments of outcomes and comparability across funds”.

Will APRA not just place pressure on funds to adjust their governance structures, processes and behaviours, but also provide direction on product and service design?

How APRA might drill down into the product level in an efficient manner is an open question. What can they handle effectively? How can they avoid regulatory over-burden? How do they share the task with ASIC?

Finally, the APRA Review seems to place store in collecting product level data as a means to identify underperforming funds, and perhaps help drive competition by informing members. More product-level data is definitely needed.

However, past performance often contains more noise than signal. And making past performance the focal point of attention can drive dysfunctional behaviours such as return-chasing, short-termism and performance manipulation. We are starting to see dysfunctionalities from the focus on fees, such as funds passing over investments that may benefit members because they are more expensive. Once stipulated and monitored, a measure can become the target in itself.

APRA might be better off focusing on how funds approach the task of delivering value to members than concentrating on past member outcomes or the intricacies of product design. Why not let the funds work out what is best for their members, and concentrate on whether they are diligently pursuing their fiduciary duty in doing so?


Geoff Warren is an Associate Professor from the College of Business and Economics at The Australian National University.



Leave a Comment:



What exactly is the ATO’s role in SMSFs?

Chris Bowen, Kevin Davis and regulators at CIFR Conference

The state of play in the funds management industry


Most viewed in recent weeks

10 little-known pension traps prove the value of advice

Most people entering retirement do not see a financial adviser, mainly due to cost. It's a major problem because there are small mistakes a retiree can make which are expensive and avoidable if a few tips were known.

Check eligibility for the Commonwealth Seniors Health Card

Eligibility for the Commonwealth Seniors Health Card has no asset test and a relatively high income test. It's worth checking eligibility and the benefits of qualifying to save on the cost of medications.

Hamish Douglass on why the movie hasn’t ended yet

The focus is on Magellan for its investment performance and departure of the CEO, but Douglass says the pandemic, inflation, rising rates and Middle East tensions have not played out. Vindication is always long term.

Start the year right with the 2022 Retiree Checklist

This is our annual checklist of what retirees need to be aware of in 2022. It is a long list of 25 items and not everything will apply to your situation. Run your eye over the benefits and entitlements.

At 98-years-old, Charlie Munger still delivers the one-liners

The Warren Buffett/Charlie Munger partnership is the stuff of legends, but even Charlie admits it is coming to an end ("I'm nearly dead"). He is one of the few people in investing prepared to say what he thinks.

Should I pay off the mortgage or top up my superannuation?

Depending on personal circumstances, it may be time to rethink the bias to paying down housing debt over wealth accumulation in super. Do the sums and ask these four questions to plan for your future.

Latest Updates

Investment strategies

Three ways index investing masks extra risk

There are thousands of different indexes, and they are not all diversified and broadly-based. Watch for concentration risk in sectors and companies, and know the underlying assets in case liquidity is needed.

Investment strategies

Will 2022 be the year for quality companies?

It is easy to feel like an investing genius over the last 10 years, with most asset classes making wonderful gains. But if there's a setback, companies like Reece, ARB, Cochlear, REA Group and CSL will recover best.


2022 outlook: buy a raincoat but don't put it on yet

In the 11th year of a bull market, near the end of the cycle, some type of correction is likely. Underneath is solid, healthy and underpinned by strong earnings growth, but there's less room for mistakes.


Time to give up on gold?

In 2021, the gold price failed to sustain its strong rise since 2018, although it recovered after early losses. But where does gold sit in a world of inflation, rising rates and a competitor like Bitcoin?

Investment strategies

Global leaders reveal surprises of 2021, challenges for 2022

In a sentence or two, global experts across many fields are asked to summarise the biggest surprise of 2021, and enduring challenges into 2022. It's a short and sweet view of the changes we are all facing.


What were the big stockmarket listings in record 2021?

In 2021, sharemarket gains supported record levels of capital raisings and IPOs in Australia. The range of deals listed here shows the maturity of the local market in providing equity capital.


Let 'er rip: how high can debt-to-GDP ratios soar?

Governments and investors have been complacent about the build up of debt, but at some level, a ceiling exists. Are we near yet? Trouble is brewing, especially in the eurozone and emerging countries.



© 2022 Morningstar, Inc. All rights reserved.

The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.